Do you have the same question? Follow this Question
Feb 06, 2026 - 03:36 PM
We’ve provided several answers to questions related to Diamox (Acetazolamide) , see some other helpful Q&A related to this product.
Question: Can acetazolamide cause nosebleeds?
Answer: Acetazolamide is not commonly associated with causing nosebleeds (epistaxis). However, rare cases of nosebleeds have been reported as a possible side effect. If you experience frequent or severe nosebleeds while taking acetazolamide, consult your healthcare provider.
Question: Should the capsule be opened or chewed?
Answer: No, the capsule should be swallowed whole and not opened, broken, or chewed. This preserves the extended-release properties, ensuring the medicine works as intended over time.
Question: What are the ATC codes for this medicine?
Answer: The ATC codes are S01EC01 and C03BA01. ATC codes (Anatomical Therapeutic Chemical Classification System) help classify drugs for research and medical use.
Question: What is the MedlinePlus reference number for this medicine?
Answer: The MedlinePlus reference number is a682756. MedlinePlus provides accessible health information to the public.
Question: What is the DrugBank ID for this medicine?
Answer: The DrugBank ID is DB00819. DrugBank IDs are used in medical and pharmaceutical databases for precise identification.
Question: What regulatory approvals does this medicine have?
Answer: It is licensed by the US FDA (United States Food and Drug Administration) and EMA (European Medicines Agency). Regulatory approval by these agencies confirms safety and efficacy standards have been met.
Question: What is the pregnancy category of this medicine?
Answer: It is in Pregnancy Category C – risk cannot be ruled out. Category C means that risk to the fetus cannot be excluded, so it should only be used if clearly needed and prescribed by a doctor.
Question: What is the protein binding rate of this medicine?
Answer: The protein binding rate is approximately 90–95%. High protein binding affects how the medicine is distributed and metabolized, impacting its effectiveness and interactions with other drugs.
Question: What is the bioavailability of this medicine?
Answer: The bioavailability is approximately 100%. High bioavailability means nearly all of the active ingredient is absorbed into the bloodstream, ensuring the medicine is effective.
Question: What are the available strengths of this medicine?
Answer: It is available in 125 mg and 250 mg tablets, as well as 500 mg extended-release capsules. Having multiple dosage options allows for flexibility in treatment plans and better accommodation of individual patient needs.
Question: What is the active ingredient in this medicine?
Answer: The active ingredient is Acetazolamide. Acetazolamide is a type of medication known as a carbonic anhydrase inhibitor, which helps to reduce fluid buildup in the body and eyes, making it valuable for treating conditions like altitude sickness and glaucoma.
